Oppenheimer & Co. Inc. Boosts Holdings in Clorox Co (CLX)

Oppenheimer & Co. Inc. raised its position in Clorox Co (NYSE:CLX) by 9.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,302 shares of the company’s stock after purchasing an additional 1,415 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Clorox were worth $2,452,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CLX. Macquarie Group Ltd. raised its position in Clorox by 437,400.0% in the second quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock valued at $236,688,000 after purchasing an additional 1,749,600 shares during the last quarter. Schroder Investment Management Group raised its position in Clorox by 57.0% in the second quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock valued at $201,641,000 after purchasing an additional 547,070 shares during the last quarter. Unigestion Holding SA bought a new position in Clorox in the second quarter valued at about $73,819,000. Morgan Stanley raised its position in Clorox by 44.2% in the second quarter. Morgan Stanley now owns 1,101,380 shares of the company’s stock valued at $148,962,000 after purchasing an additional 337,621 shares during the last quarter. Finally, FMR LLC raised its position in Clorox by 201.0% in the second quarter. FMR LLC now owns 472,179 shares of the company’s stock valued at $63,863,000 after purchasing an additional 315,298 shares during the last quarter. Hedge funds and other institutional investors own 78.38% of the company’s stock.

In related news, COO Dawn C. Willoughby sold 3,387 shares of the firm’s stock in a transaction that occurred on Wednesday, September 5th. The stock was sold at an average price of $148.01, for a total transaction of $501,309.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Linda J. Rendle sold 382 shares of the firm’s stock in a transaction that occurred on Thursday, September 6th. The stock was sold at an average price of $148.32, for a total value of $56,658.24. The disclosure for this sale can be found here. In the last three months, insiders sold 29,268 shares of company stock valued at $4,196,686. Insiders own 1.40% of the company’s stock.

Several equities analysts have commented on the company. Barclays set a $131.00 target price on Clorox and gave the company a “hold” rating in a research report on Saturday, October 6th. Wells Fargo & Co increased their target price on Clorox from $135.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 17th. ValuEngine upgraded Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. BMO Capital Markets reiterated a “buy” rating and issued a $153.00 target price on shares of Clorox in a research report on Friday, August 3rd. Finally, Goldman Sachs Group downgraded Clorox from a “neutral” rating to a “sell” rating and dropped their target price for the company from $127.00 to $112.00 in a research report on Tuesday, July 17th. They noted that the move was a valuation call. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the company. Clorox has an average rating of “Hold” and an average target price of $138.29.

Shares of CLX stock opened at $148.45 on Thursday. The stock has a market capitalization of $19.51 billion, a PE ratio of 23.71, a P/E/G ratio of 3.65 and a beta of 0.36. The company has a quick ratio of 0.67, a current ratio of 1.09 and a debt-to-equity ratio of 3.15. Clorox Co has a 1-year low of $113.57 and a 1-year high of $155.23.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.59 by $0.03. The company had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.53 billion. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The business’s quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.46 earnings per share. As a group, research analysts predict that Clorox Co will post 6.41 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Stockholders of record on Wednesday, October 31st will be paid a $0.96 dividend. The ex-dividend date is Tuesday, October 30th. This represents a $3.84 annualized dividend and a dividend yield of 2.59%. Clorox’s payout ratio is 61.34%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: How can investors find ex-dividend dates?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply